Publikationen, an denen er mitarbeitet R. Ruiz (10)

2019

  1. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry

    JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548

  2. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    American Heart Journal, Vol. 213, pp. 35-46

  3. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry

    Clinical Cardiology, Vol. 42, Núm. 5, pp. 553-560

2018

  1. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry

    European Heart Journal, Vol. 39, Núm. 6, pp. 464-473

  2. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

    Heart, Vol. 103, Núm. 4, pp. 307-314

  2. Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry

    BMJ Open, Vol. 7, Núm. 3

  3. Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

    BMJ Open, Vol. 7, Núm. 12

2016

  1. Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry

    PLoS ONE, Vol. 11, Núm. 10

  2. Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    European Heart Journal, Vol. 37, Núm. 38, pp. 2882-2889